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Abstract
Background: An evidence-based, step-by-step guide, the 4 Pillars™ Practice Transformation Program, was the
foundation of an intervention to increase adult immunizations in primary care and was tested in a randomized
controlled cluster trial. The purpose of this study is to report changes in influenza immunization rates and on
factors related to receipt of influenza vaccine.
Methods: Twenty five primary care practices were recruited in 2013, stratified by city (Houston, Pittsburgh), location
(rural, urban, suburban) and type (family medicine, internal medicine), and randomized to the intervention (n = 13)
or control (n = 12) in Year 1 (2013-14). A follow-up intervention occurred in Year 2 (2014-15). Demographic and
vaccination data were derived from de-identified electronic medical record extractions.
Results: A cohort of 70,549 adults seen in their respective practices (n = 24 with 1 drop out) at least once each year
was followed. Baseline mean age was 55.1 years, 35 % were men, 21 % were non-white and 35 % were Hispanic.
After one year, both intervention and control arms significantly (P < 0.001) increased influenza vaccination, with
average increases of 2.7 to 6.5 percentage points. In regression analyses, likelihood of influenza vaccination was
significantly higher in sites with lower percentages of patients with missed opportunities (P < 0.001) and, after
adjusting for missed opportunities, the intervention further improved vaccination rates in Houston (lower baseline
rates) but not Pittsburgh (higher baseline rates). In the follow-up intervention, the likelihood of vaccination
increased for both intervention sites and those that reduced missed opportunities (P < 0.005).
Conclusions: Reducing missed opportunities across the practice increases likelihood of influenza vaccination of
adults. The 4 Pillars™ Practice Transformation Program provides strategies for reducing missed opportunities to
vaccinate adults.
Trial registration: This study was registered as a clinical trial on 03/20/2013 at ClinicalTrials.gov, Clinical Trial
Registry Number: NCT01868334, with a date of enrollment of the first participant to the trial of April 1, 2013.
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Background
Adult influenza vaccination rates in the United States
(U.S.) continue to languish at approximately 44 % as of
2014-2015 reported estimates [1], with annual increases
hovering at less than 2 percentage points [2, 3]. The rea-
sons for the disparity between reported rates in the com-
munity, the desired rate of 70 % [4] set forth in the
Healthy People 2020, and meaningful annual increases
are legion. They include logistical issues at the practice
level such as storage, cost [5], return policies for unused
vaccine, and choice of vaccines; strongly held personal
beliefs about influenza vaccine at the patient level such
as belief that the vaccine is not necessary, effective or
safe [6]; and broader issues such as, changes in year-to-
year effectiveness, timing of vaccine distribution [7] and
vaccine administration reimbursement.
Several system-level efforts have been undertaken or
implemented that have attenuated some of the barriers
to vaccination. The Affordable Care Act requires that
certain preventive services including immunizations be
covered as part of basic care [8]. This mandate should
effectively eliminate patients’ financial barriers to receiv-
ing influenza vaccine. The Centers for Disease Control
and Prevention (CDC) encourages vaccine distribution
policies that are designed to reduce regional and local
shortages of vaccine, i.e., partial orders are shipped na-
tionwide and orders are completed later as more stock
becomes available [7]. An increasing number of hospitals
and health systems now require their employees to re-
ceive influenza vaccine [9, 10].
To have any hope of attaining the Healthy People
2020 goal, a business-as-usual approach to increasing in-
fluenza vaccine uptake is no longer acceptable. A single
strategy is unlikely to be successful. The Task Force on
Community Preventive Services has recommended
multi-strategy, evidence-based interventions [11] as an
effective means of increasing immunization rates. These
interventions should enhance access to vaccination ser-
vices, increase community demand for vaccines, and im-
prove provider- or system-based interventions.
The 4 Pillars™ Practice Transformation Program, also
known as the 4 Pillars™ Immunization Toolkit, (4pillar-
stoolkit.pitt.edu) is a compilation of evidence-based best
practices for increasing immunizations in primary care
settings. It is built on decades of research by the investi-
gators into the barriers to and facilitators of adult immu-
nizations from the provider and patient perspectives,
and trials of successful strategies. The 4 Pillars™ Program
was the foundation of an intervention implemented in a
randomized controlled cluster trial (RCCT), to increase
adult immunization rates and reduce missed opportun-
ities to vaccinate among patients of primary care prac-
tices in Pittsburgh and Houston [12]. The purpose of
this study is to report on changes in adult influenza
immunization rates and on factors related to the likeli-
hood of receipt of influenza vaccine.
Methods
This RCCT took place during 2013-2014 and 2014-2015
with baseline in 2012-2013, and was approved by the In-
stitutional Review Boards of the University of Pittsburgh,
Baylor College of Medicine and Harris Health System.
Sample size and sites
Optimal Design software (University of Michigan, Ver-
sion 1.77, 2006) was used to calculate sample size for a
randomized trial seeking a 10-15 % absolute increase in
vaccination rate with a minimum practice size of 100 pa-
tients. A sample size of 20 clusters or sites (10 Interven-
tion and 10 Control practices) was determined to be
necessary to achieve 80 % power with an alpha of 0.05.
Eligible primary care family medicine (FM) and internal
medicine (IM) practices from a practice-based research
network (PBRN) in Pittsburgh (FM Pittnet), a clinical
network in Southwestern Pennsylvania (UPMC Commu-
nity Medicine, Inc.) and a PBRN in Houston (SPUR-
Net) were solicited for participation. All Houston sites
were publicly funded, safety net practices, caring for a
disadvantaged population; whereas, Pittsburgh practices
were smaller private practices or residency sites with pa-
tients from across the socioeconomic spectrum. When
25 sites agreed to participate, solicitation ceased. All
sites used a common electronic medical record (EMR),
EpicCare within their respective health systems.
Cluster randomization
Cluster randomization allocates clinical practices rather
than individuals to the intervention arms [13]; thus, each
site or office (some practices had more than one) was
considered as a cluster. Eligibility requirements included
having a significant adult practice, preliminary baseline
vaccination rates for at least one adult vaccine <50 %
and a willingness to make office changes to increase in-
fluenza, pneumococcal and Tdap vaccination rates. Par-
ticipating practices were stratified first by metropolitan
area (Pittsburgh or Houston), then in Pittsburgh only, by
location (urban, suburban or rural) and by discipline
(IM or FM). The practices were then randomized into
the intervention or control arms within strata (Fig. 1).
Year 2 control practices were informed that their inter-
vention would take place the following season and were
not contacted again until the next year.
4 Pillars™ program
The 4 Pillars™ Practice Transformation Program is
founded on four evidence-based [11, 14, 15] key do-
mains: Pillar 1 - Convenient vaccination services; Pillar 2
- Communication with patients about the importance of
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immunization and the availability of vaccines; Pillar 3 -
Enhanced office systems to facilitate immunization; and
Pillar 4 - Motivation through an office immunization
champion (Champion). Table 1 describes the primary
strategies contained in the 4 Pillars™ Program. The 4 Pil-
lars™ Program includes background on the importance
of protecting patients against vaccine-preventable dis-
eases, barriers to vaccination from both provider and pa-
tient perspectives and strategies to eliminate those
barriers. Practices were expected to implement strategies
from each of the 4 pillars.
The 4 Pillars™ Program was provided as a printed and
bound document, supplemented by a web-based practice
transformation dashboard. The dashboard was devel-
oped from the work of Fixsen et al. [16], who established
an empirically-based implementation framework that in-
cludes systematic uptake, establishment, and mainten-
ance of research findings into routine practice. The core
components include: staff selection and training on the
specific evidence-based practices, expert consultation
and coaching of staff and administration, program evalu-
ation to assess and provide feedback, facilitative admin-
istrative supports to ensure data are used to focus and
inform decision making, and systems interventions.
Once the practice was registered, any staff member
could log into the dashboard. The Champion was re-
sponsible for registering the practice and its staff mem-
bers, and identifying strategies that the practice would
implement. The 4 Pillars™ Program provided step-by-
step guidance for implementing the strategies, and the
dashboard showed the practices’ progress through the
change process. Practices could monitor their progress
on graphs that reported biweekly numbers of vaccines
given.
Interventions
The intervention was designed using Diffusion of Inno-
vations theory [17], and included the 4 Pillars™ Practice
Transformation Program, provider education, and one-
on-one coaching of the immunization champion for
each practice. Two of the investigators (AEB, MPN) vis-
ited the intervention sites each year to introduce the
study and the 4 Pillars™ Program and to work with staff
to develop practice-specific ideas for implementing
strategies.
Each practice was asked to identify a Champion who
would be responsible for updating the practice trans-
formation dashboard as intervention strategies were
employed to guide strategy implementation. Other tasks





















































Fig. 1 Randomization Scheme
Lin et al. BMC Infectious Diseases  (2016) 16:623 Page 3 of 11
telephone call with a research liaison for coaching, en-
suring that chosen strategies were being implemented,
and working to maintain motivation of the staff.
Each practice was given a graph showing biweekly pro-
gress towards their goal based on an overall 20 % in-
crease over the previous year’s total adult influenza
vaccines given. These graphs were to be used by the
Champion to encourage the staff to maintain motivation
or stimulate additional changes to increase vaccination
rates. The research liaison discussed these graphs with
the Champions during their calls or visits.
Data collection
De-identified demographic, office visit and vaccination
data were derived from EMR data extractions performed
by the UPMC Center for Assistance in Research using
the eRecord and from a similar EMR extraction by staff
of the SPUR-NET for the Houston sites. A longitudinal
data base was created with only those patients who had
a visit each year during all three years, creating a cohort
of individuals who would have been patients of the prac-
tice during the entire study period.
Statistical analyses
Descriptive analyses were performed for patient demo-
graphic characteristics (age, sex, race, ethnicity, and
health insurance). Because of significant differences in
patient populations, size and structure of the practices
in Houston and Pittsburgh, the respective sites were
grouped separately for analysis. Age was used as a con-
tinuous variable. Race and ethnicity were recorded dif-
ferently in each city. In Pittsburgh sites, with few
Hispanic patients, ethnicity was rarely recorded; hence
patients were grouped by race into white and non-white
with blacks and Hispanics assigned to the non-white
group and only race data are presented and used in ana-
lysis. In Houston sites, with few non-Hispanic patients,
race was rarely recorded; hence only ethnicity (Hispanic
and non-Hispanic) is presented and used in analysis.
Proportions were reported for categorical variables and
means and standard deviations were reported for con-
tinuous variables.
The primary outcome measure, influenza vaccination
rate was reported at the end of baseline (8/1/2012-1/31/
2013) and the end of the intervention period (8/1/2013-
1/31/2014) by site and by intervention group for the
Year 1 RCCT analyses. At the end of Year 1, practices
were offered the opportunity to continue active inter-
vention during Year 2. Four practices opted to do so. At
the same time, the Year 1 control sites began the inter-
vention. For the Year 2 pre-post analyses, the four prac-
tices in Pittsburgh that continued the intervention in
Year 2 were combined with the Year 1 control sites and
were referred to as the active intervention group. The
Table 1 Intervention strategies used to increase adult
vaccination rates from the 4 pillars™ practice transformation
program
Pillar 1 Convenient vaccination services
• Use every patient visit type as an opportunity to vaccinate.
• Offer open access/walk-in vaccination during office hours.
• Hold express vaccination clinics outside normal office hours
where only influenza vaccine is offered and systems for check-in,
screening, and record keeping are streamlined.
• Create a dedicated vaccination station.
• Extend the influenza vaccination season by vaccinating as soon
as supplies arrive and continuing to vaccinate as long as flu is
circulating in the community.
Pillar 2 Communication with patients about the importance of
vaccination and the availability of vaccines
• Train staff to discuss influenza vaccine during routine processes
such as vital signs
• Discuss the serious nature of influenza
• Promote vaccination of staff to set a good example
• Record telephone on-hold messages that advertise vaccine
availability or promote vaccination.
• Use posters/fliers/electronic message board/website postings/social
media promoting vaccination
• Conduct outreach by email, phone, text, mail, health portal, etc.
that vaccines are due and/or available
Pillar 3 Enhanced office systems to facilitate adult vaccination
• Assess vaccination eligibility for every scheduled patient at the
beginning of the day and discuss in daily huddles
• Assess immunizations as part of vital signs upon rooming
patients and record outside vaccinations in EMR
• Incorporate EMR prompts for vaccination into the workflow
• Incorporate standing order programs (SOP) for vaccination
by nurses and/or medical assistants into the workflow
• Ensure sufficient vaccine inventory to handle increased
immunizations
• Promote simultaneous vaccination (e.g., offer other vaccines
at the time of influenza vaccination)
Pillar 4 Motivation through an office immunization champion
• Create a chart to track progress. Set an improvement goal
and regularly track progress (e.g., daily or weekly). Post the
graph of your progress in a prominent location and update
it regularly.
• Provide ongoing feedback to staff on vaccination progress
using email, posted notices, making announcements, or using
a combination of these. Encourage, nudge, and cheer as
needed to keep up the momentum.
• Report upon progress at staff or huddle meetings. Facilitate
discussion at these meetings to identify which pillar activities
are working, which are not working and why, and to identify
changes that need to be made.
• Create a competitive challenge among your staff for the
most vaccinations given.
• Provide rewards for successful results to create a fun-spirited
environment that promotes vaccination across the practice.
Ideas include: reward for highest vaccinator, team competitions,
vaccination goal poster contest, etc.
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six practices that did not actively participate in Year 2
were referred to as the maintenance group. In Houston,
the Year 1 intervention sites were referred to as the
maintenance group and the Year 1 control sites that re-
ceived the intervention in Year 2 were referred to as the
active intervention group.
The August through January dates were used because
the new seasonal influenza vaccines typically begin to ar-
rive at practices in August and the majority of adult
influenza vaccines are given by the end of January.
Missed opportunities for all patients who were seen dur-
ing the influenza vaccination seasons (8/1/2013-1/31/
2014 and 8/1/2014-1/31/2015) were determined to be all
visits in which an influenza vaccine was not received
until vaccination or the end of the influenza season (1/
31). The visit in which an influenza vaccine was given
and post vaccination visits were not counted. Patients
who were not seen at all during the influenza vaccination
Table 2 Demographic and practice characteristics by practice and intervention group at baseline
Site N Age, yrs. Mean (SD) Female, % White, % Non-white, % Hispanic, % Health insurance status
Medicaid,a% Commercial, % Medicare, %
Pittsburgh sites
Intervention
B 529 65.5 (14.6) 69.8 58.0 41.2 0.4 15.1 42.0 42.9
C 2179 60.1 (17.4) 60.3 99.4 0.3 0.1 11.7 58.5 29.8
D 3224 66.8 (14.7) 52.2 99.6 0.2 0.1 6.2 56.3 37.5
E 1392 56.5 (15.9) 58.6 95.1 4.7 0.1 14.5 61.9 23.6
G 417 67.0 (14.3) 52.0 82.5 16.6 0.0 5.3 49.2 45.6
H 306 66.7 (14.9) 59.2 62.4 37.0 0.0 13.7 41.5 44.8
F 3611 58.1 (17.0) 56.8 96.4 2.4 0.3 5.0 62.6 32.4
J 603 62.2 (18.6) 52.7 85.9 13.3 0.2 9.0 61.4 29.7
K 330 56.0 (17.7) 67.6 99.1 0.3 0.3 16.4 61.5 22.1
M 595 66.4 (14.9) 51.1 98.0 0.2 0.3 6.7 58.8 34.5
Total 13,186 61.7 (16.7) 56.7 94.3 5.0 0.2 10.0 59.4 30.6
Control
N 2102 62.0 (16.4) 58.3 6.6 0.4 0.1 8.1 67.5 24.4
O 4324 57.2 (16.0) 53.9 98.6 0.7 0.1 7.4 65.0 27.6
R 2534 58.8 (14.6) 52.3 97.8 1.2 0.2 4.8 67.6 27.7
S 1645 43.6 (16.7) 75.1 53.3 45.7 0.8 58.4 23.4 18.2
U 2612 57.1 (17.3) 63.9 90.9 7.9 0.3 11.6 53.0 35.4
W 224 78.6 (10.4) 72.8 92.4 6.3 0.9 2.2 46.0 51.8
X 1010 53.3 (15.0) 46.6 96.5 2.0 0.0 12.0 64.5 23.6
Y 3334 60.2 (15.8) 58.9 97.6 1.7 0.1 7.9 60.7 31.5
Total 17,185 57.8 (16.6) 57.8 94.2 5.8 0.2 11.1 60.2 28.7
Houston sites
Intervention
A 4880 52.6 (13.7) 68.8 8.0 19.7 72.3 83.8 4.8 11.5
I 8527 53.3 (13.7) 70.7 2.7 67.6 29.6 82.9 1.5 15.6
L 5867 51.9 (12.0) 72.6 13.1 9.3 77.6 94.5 0.8 4.7
Total 19,274 51.0 (13.0) 72.0 6.0 94.0 67.0 86.7 2.1 11.2
Control
P 6388 51.8 (13.4) 73.0 4.1 13.9 82.0 91.7 1.1 7.1
T 5547 50.9 (12.9) 69.5 11.1 28.7 60.2 90.8 2.3 6.9
V 8969 50.7 (13.2) 73.7 4.0 35.6 60.3 95.1 0.6 4.3
Total 20,904 53.0 (13.0) 71.0 7.0 93.0 55.0 92.9 1.2 5.8
aAlso includes Other/self-pay/indigent/charity care
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season were assigned a single missed opportunity to ac-
count for the fact that they should have been encouraged to
come in for a vaccine. Missed opportunities were used as a
measure of how well sites incorporated 4 Pillars™ Program
strategies and how effective those strategies were. The
proportion of patients with one or more missed opportun-
ities was determined for each practice.
Cochran-Armitage trend tests were performed for de-
termining percentage point differences between the
baseline and intervention periods for the Year 1 RCCT
Table 3 Influenza vaccination rates and missed vaccination opportunities during the Year 1 randomized controlled cluster trial by
practice, intervention group and city
Site Total N % Vaccinated % of Patients with ≥1 Missed Opportunities
Baseline Year 1 PP
Difference
Baseline Year 1 PP
Difference8/1/2012-1/31/2013 8/1/2013-1/31/2014 8/1/2012-1/31/2013 8/1/2013-1/31/2014
Pittsburgh sites
Intervention
B 529 49.0 50.5 1.5 79.0 76.0 -3.0
C 2179 57.9 65.0 7.1 65.9 62.6 -3.3
D 3224 54.6 59.3 4.7 66.1 64.1 -2.0
E 1392 47.4 54.2 6.8 78.0 71.2 -6.8
G 417 51.8 54.0 2.2 70.5 69.5 -1.0
H 306 53.3 48.0 -5.3 77.8 69.9 -7.9
F 3611 56.0 60.6 4.6 66.7 67.0 0.3
J 603 49.1 54.7 5.6 70.7 65.7 -5.0
K 330 23.6 30.9 7.3 91.5 89.4 -2.1
M 595 62.0 68.1 6.1 66.9 62.2 -4.7
Total 13,186 53.7 58.7 5.0*† 69.3 66.8 -2.5*†
Control
N 2102 60.2 61.8 1.6 71.2 67.4 -3.8
O 4324 35.3 50.9 15.6 76.5 68.9 -7.6
R 2534 42.3 46.7 4.4 76.1 70.5 -5.6
S 1045 35.3 36.0 0.7 83.8 81.3 -2.5
U 2612 52.9 54.2 1.3 68.2 71.2 3.0
W 224 61.2 75.0 13.8 66.1 53.6 -12.5
X 1010 47.2 56.6 9.4 72.5 70.1 -2.4
Y 3334 54.3 58.2 3.9 70.6 68.2 -2.4
Total 17,185 46.8 53.3 6.5*† 73.4 69.8 -3.6*†
Houston sites
Intervention
A 4880 43.4 47.9 4.5 79.3 78.3 -1.0
I 8527 33.2 37.4 4.2 82.7 85.0 2.3
L 5867 36.1 35.2 -0.9 82.0 86.2 4.2
Total 19,274 36.7 39.4 2.7*† 81.6 83.7 2.1*†
Control
P 6388 36.6 46.9 10.3 82.5 79.8 -2.7
T 5547 32.2 40.7 8.5 82.6 79.5 -3.1
V 8969 47.0 46.4 -0.6 73.8 76.1 2.3
Total 20,904 39.9 45.1 5.2*† 78.8 78.1 -0.7*†
Note: PP percentage point difference between baseline and Year 1 vaccination rates and percent of patients with ≥1 missed opportunities. A decrease in missed
opportunities is the desired outcome
*P value is a two-sided probability from Cochran-Armitage trend test for percentage point difference between Baseline and Year 1 (P < 0.001)
†P value is a two-sided probability from chi-square test for percentage point difference between intervention and control groups (P < 0.001)
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and active intervention and maintenance for the Year 2
pre-post study for influenza vaccination rates and pro-
portion of the patients with ≥1 missed opportunity [18].
Chi-square tests were used to compare the PP changes
from baseline to follow up between groups.
To determine which factors were related to influenza
vaccination rates, while accounting for the clustered nature
of the data, generalized estimating equation (GEE) models
were used to examine the likelihood of influenza vaccin-
ation after the intervention period, taking account of
heterogeneity in demographic characteristics (including
age, sex, and race/ethnicity and health insurance status) as
well as the site - level variables intervention arm and
proportion of patients with missed opportunities. An un-
structured correlation matrix was used to accommodate
the within-patient variation due to repeated annual meas-
urement of influenza vaccination. Statistical significance of
two-sided tests was set at type I error (alpha) equal to 0.05.
All analytical procedures were performed using SAS® 9.3.
Results
Twenty-four sites completed the Year 1 intervention
(one site dropped out); their demographic and other
characteristics are shown in Table 2. Houston sites were
part of a publicly funded safety net system which were
established to care for uninsured/underinsured patients;
whereas, Pittsburgh sites were both training/residency
sites and private practices. Houston sites were larger
with higher proportions of Hispanic patients, female pa-
tients, and non-commercially insured patients than
Pittsburgh sites. For these reasons, the results are pre-
sented separately for each city.
Year 1 - RCCT
Table 3 shows the influenza vaccination rates for each
site and each intervention group for the baseline and
intervention periods. Vaccination rates ranged from a
low of 23.6 % to a high of 62 % at baseline across all
sites. During the intervention, Pittsburgh intervention
sites significantly increased influenza vaccination rates
an average of 5.0 PP (P < 0.001), while control sites sig-
nificantly increased influenza vaccination an average of
6.5 PP (P < 0.001). In Houston, intervention sites signifi-
cantly increased influenza vaccination an average 2.7 PP,
while control sites increased influenza vaccination an
average of 5.2 PP (P < 0.001). Influenza vaccination in-
creased more in both the control groups than interven-
tion groups (P < 0.001). At the same time, the percent of
patients with at least one missed opportunity to vaccin-
ate decreased in the Pittsburgh intervention and control
groups and the Houston control group (P < 0.001).
In GEE regressions (Table 4), in the Pittsburgh sites,
which had higher baseline rates, likelihood of influenza
vaccination was significantly higher for females, older
patients, white patients and those with commercial in-
surance or Medicare. While those in the intervention
group were not more likely to receive influenza vaccine,
those patients in practices having fewer patients with at
least one missed opportunity were more likely to receive
the vaccine (P < 0.05). In the Houston sites, the likeli-
hood of influenza vaccination was significantly higher
among those who were older, of Hispanic ethnicity, in
the intervention group and in practices with fewer
missed opportunities (P < 0.05).
Year 2 – pre-post study
During the Year 2 pre-post study, vaccination rates
(Table 5) among the active intervention groups in the
pre-intervention period were 54.5 % for Pittsburgh and
44.7 % for Houston; whereas vaccination rates for the
maintenance groups were 55.2 % for Pittsburgh and
40.2 % for Houston, at the beginning of their mainten-
ance period. At the end of the Year 2 intervention
period, both the active intervention and maintenance
groups significantly increased influenza rates and de-
creased proportion of patients with missed opportunities
Table 4 Likelihood of influenza vaccination at the end of the year 1 randomized controlled cluster trial (1/31/2014) using
generalized estimating equations, by city
Variable Pittsburgh Houston
Odds Ratio (95 % CI) P Value Odds Ratio (95 % CI) P Value
Patient level variables
Female, ref. = male 1.08 (1.03-1.13) 0.002 0.98 (0.93-1.03) 0.170
Age, years 1.04 (1.04-1.04) <0.001 1.03 (1.03-1.03) <0.001
White race, ref. = Non-white 1.16 (1.04-1.30) 0.007 – –
Hispanic ethnicity, ref. = Non-Hispanic – – 1.12 (1.08-1.16) <0.001
Medicaid, charity care, uninsured, ref. = Commercial insurance +Medicare 0.97 (0.89-1.05) 0.050 0.95 (0.88-1.02) 0.153
Site level variables
Intervention, ref. = Control 1.00 (0.95-1.05) 0.950 1.06 (1.00-1.13) 0.048
Patients with ≥1 missed opportunities, % 0.94 (0.94-0.95) <0.001 0.94 (0.94-0.95) <0.001
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in both cities. In bivariate analyses, the change in influ-
enza vaccination did not differ between groups, in Pitts-
burgh, but was significantly higher in the active
intervention group than the maintenance group in
Houston (P < 0.001)
In GEE regression analyses (Table 6) in Pittsburgh,
older age, being female, as well as being in the interven-
tion group and being a patient at a site with fewer
missed opportunities were related to increased likelihood
of influenza vaccination (P < 0.05). Similarly in Houston,
Table 5 Influenza vaccination rates and missed opportunities during the year 2 pre-post study by practice, intervention group
and city




Difference8/1/2013-1/31/2014 8/1/2014-1/31/2015 8/1/2013-1/31/2014 8/1/2014-1/31/2015
Pittsburgh sites
Maintenance
B 529 50.5 53.3 2.8 76.0 60.9 -15.1
C 2179 65.0 63.4 -1.6 62.6 60.1 -2.5
D 3224 59.3 61.3 2.0 64.1 61.8 -2.3
E 1392 54.2 49.1 -5.1 71.2 73.2 2.0
G 417 54.0 62.1 8.2 69.5 64.3 -5.2
H 306 48.0 50.0 2.0 69.9 73.2 3.3
Total 8047 55.2 56.5 1.4* 68.9 65.6 -3.3*
Active Intervention
F 3611 60.6 65.3 4.7 67.0 58.7 -8.3
J 603 54.7 54.9 0.2 65.7 65.3 -0.4
K 330 30.9 28.2 -2.7 89.4 92.4 3.0
M 595 68.1 79.5 11.4 62.2 52.6 -9.6
N 2102 61.8 59.0 -2.8 67.4 65.5 -1.9
O 4324 50.9 46.3 -4.6 68.9 68.7 -0.2
R 2534 46.7 41.9 -4.8 70.5 73.5 3.0
S 1045 36.0 40.1 4.1 81.3 81.4 0.1
U 2612 54.2 58.2 4.0 71.2 62.5 -8.7
W 224 75.0 75.9 0.9 53.6 53.6 0
X 1010 56.6 59.9 3.3 70.1 64.0 -6.1
Y 3334 58.2 61.8 3.6 68.2 59.8 -8.4
Total 22,324 54.5 55.9 1.44* 69.6 66.5 -3.1*
Houston sites
Maintenance
A 4880 47.9 48.4 0.5 78.3 79.2 0.9
I 8527 37.4 35.3 -2.1 85.0 86.5 1.5
L 5867 35.2 40.0 4.9 86.2 81.6 -4.6
Total 19,274 40.2 41.2 1.7*† 83.2 82.4 -0.7**†
Active intervention
P 6388 46.9 49.8 2.9 79.8 75.9 -3.9
T 5547 40.7 46.3 5.7 79.5 73.5 -6.0
V 8969 46.4 48.8 2.4 76.1 74.9 -1.2
Total 20,904 44.7 48.3 3.6*† 78.5 74.8 -3.7*†
Note: PP Percentage point difference between pre (Year 1) and post (Year 2). A decrease in missed opportunities is the desired outcome
*P value is a two-sided probability from Cochran-Armitage trend test for difference between pre and post intervention (P < 0.001)
**P value is a two-sided probability from Cochran-Armitage trend test for difference between pre and post intervention (P < 0.05)
†P value is a two-sided probability from chi-square test of PP differences between intervention arms
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older age, being female, Hispanic, in the intervention
group and in a site with fewer missed opportunities were
all related to increased likelihood of influenza vaccin-
ation (P < 0.01).
Discussion
Secular trends in U.S. adult influenza vaccination rates
indicate a slow increase in vaccination of approximately
2 percentage points per year. At this rate, it would take
nearly 15 years to achieve the national goal of 70 % [4],
given the distance between that goal and the current na-
tional rate of 42 % [19]. In our randomized controlled
cluster trial, all groups increased vaccine uptake by 2.7-
6.5 %, suggesting that the intervention using the 4 Pil-
lars™ Practice Transformation Program was not more ef-
fective than secular trends. Variation in the level of
improvement among practices was noted, with some
sites making little to no improvement. Research has
shown that impediments to successful quality improve-
ment projects include not having allocated time to de-
vote to the project, lack of leadership support, not
having a performance assessment and not having a pro-
ject champion [20]. In this study, some Champions did
not hold positions of influence in the practice and/or
were not allowed work time to use the online 4 Pillars™
Program and dashboard to take advantage of the re-
sources and guidance provided therein. Other issues that
may have hindered practice change were 1) the lead
physician in one small practice was nearing retirement,
hence was not engaged in the effort; b) one site was lo-
cated in a rural Amish community with high vaccine re-
fusal rates; 3) late delivery of influenza vaccine in Year 1
in the Pittsburgh sites; and 4) feedback to the sites on
immunization progress was delayed.
When the control groups were offered the interven-
tion and the intervention groups were in maintenance,
small additional gains in influenza vaccination rates were
realized in the active intervention groups, with no loss
among maintenance groups, suggesting that behavior
changes to improve vaccination were persisting.
Research has shown that missed opportunities to vac-
cinate are frequently associated with low vaccination
rates [21–24]. In one study, among unvaccinated high
risk adults, 90 % reported at least one visit in which in-
fluenza vaccine could have been administered [25]. The
regression analyses in this study supported those find-
ings and indicated that reducing missed opportunities is
a critical element in increasing influenza vaccination.
The intervention increased the likelihood of influenza
vaccination when missed opportunities decreased in the
practices. The 4 Pillars™ Program recommends standing
order protocols for clinical staff to offer vaccines,
reviewing vaccination status at every visit and offering
express vaccine services such as influenza vaccine-only
clinics, and walk-in vaccinations during influenza vaccin-
ation season. Consistent use of these strategies should
reduce the number of missed opportunities and in turn
increase vaccination rates [11, 26]. We believe that rou-
tine assessment of vaccination status that triggers stand-
ing orders is a powerful combination (Pillar 3).
Strengths and limitations
The strengths of this study are its randomized design, the
large number and diversity of patients and practice set-
tings including safety net clinics, and two intervention
years of vaccination reporting. These factors enhance its
generalizability. The study’s limitations include late deliv-
ery of influenza vaccine in Year 1 in the Pittsburgh sites
that may have diminished the intervention effect. During
the first intervention year, delivery of the EMR data was
delayed, preventing the research team from providing
feedback about their progress to the sites in both cities
early in the intervention. Increases in vaccinations in the
control arm when those sites were not in an intervention
group may be due to a Hawthorne effect or transference
from the intervention and have been reported in other
Table 6 Likelihood of influenza vaccination at the end of the year 2 pre-post study (1/31/2015) using generalized estimating
equations, by city
Variable Pittsburgh Houston
Odds Ratio (95 % CI) P Value Odds Ratio (95 % CI) P Value
Patient level variables
Female, ref. = male 1.12 (1.02-1.22) <0.030 1.12 (1.08-1.16) <0.001
Age, years 1.04 (1.04-1.04) <0.001 1.03 (1.02-1.03) <0.001
White race, ref. = Non-white 0.99 (0.85-1.13) 0.586 – –
Hispanic ethnicity, ref. = Non-Hispanic – – 1.25 (1.21-1.29) <0.001
Medicaid, charity care, uninsured, ref. = Commercial insurance +Medicare 1.03 (0.91-1.15) 0.856 1.05 (0.95-1.16) 0.357
Site level variables
Active intervention, ref. = Maintenance group 1.08 (1.03-1.14) 0.003 1.10 (1.40-1.17) 0.002
Patients with ≥1 missed opportunities, % 0.95 (0.95-0.96) <0.001 0.96 (0.95-0.96) <0.001
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studies [27]; secular trends are smaller than the changes
noted in this study.
Conclusions
As the national adult influenza vaccination rate con-
tinues to creep towards national goals, strategies are
needed to jumpstart efforts to increase the rate of im-
provement. An intervention that includes the 4 Pillars™
Practice Transformation Program can assist primary care
practices with reducing missed opportunities to vaccin-
ate thus increasing adult influenza vaccination rates.
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